NCT02860676 2025-12-15
Extension Study of UC-961 (Cirmtuzumab) for Patients With Chronic Lymphocytic Leukemia Treated Previously With UC-961
University of California, San Diego
Phase 1 Completed
Clinical Trials
5 trialsNCT04501939 2025-09-02
Venetoclax
University of California, San Diego
Phase 2 Active not recruiting
NCT02776917 2025-08-07
Study of Cirmtuzumab and Paclitaxel for Metastatic or Locally Advanced, Unresectable Breast Cancer
University of California, San Diego
Phase 1 Completed
NCT05156905 2024-10-09
Study of Docetaxel Combined with Cirmtuzumab in Metastatic Castration Resistant Prostate Cancer
University of California, San Diego
Phase 1 Terminated
NCT02222688 2020-08-13
UC-961 (Cirmtuzumab) in Relapsed or Refractory Chronic Lymphocytic Leukemia
University of California, San Diego
Phase 1 Completed